Six Weeks of Endurance Training Activates Brown Fat for Better Metabolism
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
20 articles
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.
A completed OSU trial investigates whether short-term exercise training can restore impaired mitochondrial cleanup pathways in overweight and obese skeletal muscle.
New research shows high-intensity interval training just once per week can improve obesity and fatty liver disease over a full year.
A completed University of Michigan trial explored how aerobic exercise training alters RAGE-mediated inflammatory pathways in type 2 diabetic adults.
New study tests whether meal timing combined with Mediterranean diet can reverse fatty liver disease better than diet alone.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
16-week study explores how 8-hour eating windows affect different types of obesity and metabolic health markers.
German researchers test whether natural foods plus digital coaching can match diabetes remission rates of formula diets.
Small study explores whether eating within 9-hour windows can improve blood sugar control and metabolic health in diabetic patients.
UCSF study tests whether eating within specific time windows can help obese adults lose weight more effectively than traditional dieting.
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
Faith-based weight loss trial compares intermittent fasting to continuous calorie reduction for cancer risk reduction in Black adults.
Australian study compares calorie restriction with time-restricted eating for reducing diabetes and heart disease risk factors.
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
411-person study shows digital insulin delivery system helps optimize glucose control through automated dose tracking and mobile integration.
University of Pennsylvania study tests behavioral tools to help people stick with time-restricted eating for blood pressure and weight management.